Cancer Science 2019: Overexpression of PARP is an independent prognostic marker for poor survival in Middle Eastern breast cancer and its inhibition can be enhanced with embelin co-treatment - Prof. Khawla Al-Kuraya - Director of the Research Centre at King Fahad National Centre for ChildrenÃ?¢Ã?â?¬Ã?â?¢s Cancer, King Faisal Specialist Hospital and Research (KFSH) in Riyadh, Saudi Arabia
that selectively kills cancer cells with deficient BRCA1 and BRCA 2, which encode proteins known to function in DNA repair through homologous recombination (HR). However, BRCA – mutant tumors represent only

